Concepts (324)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vitamin D | 25 | 2018 | 187 | 3.180 |
Why?
|
| Vitamin D Deficiency | 17 | 2018 | 89 | 2.390 |
Why?
|
| Obesity | 29 | 2020 | 1244 | 2.100 |
Why?
|
| Aging | 26 | 2020 | 1010 | 2.070 |
Why?
|
| Body Composition | 19 | 2020 | 415 | 1.670 |
Why?
|
| Weight Loss | 14 | 2020 | 493 | 1.670 |
Why?
|
| Mobility Limitation | 7 | 2017 | 222 | 1.340 |
Why?
|
| Aged | 76 | 2020 | 10999 | 1.260 |
Why?
|
| Dietary Proteins | 8 | 2020 | 66 | 1.130 |
Why?
|
| Overweight | 6 | 2018 | 288 | 1.120 |
Why?
|
| Life Style | 8 | 2020 | 418 | 1.120 |
Why?
|
| Body Mass Index | 24 | 2019 | 953 | 1.080 |
Why?
|
| European Continental Ancestry Group | 26 | 2018 | 1176 | 1.070 |
Why?
|
| Physical Fitness | 5 | 2012 | 135 | 1.040 |
Why?
|
| Exercise | 7 | 2019 | 700 | 1.030 |
Why?
|
| Polymorphism, Single Nucleotide | 21 | 2018 | 1078 | 1.010 |
Why?
|
| Female | 81 | 2020 | 21491 | 0.960 |
Why?
|
| Male | 78 | 2020 | 20697 | 0.950 |
Why?
|
| Caloric Restriction | 4 | 2019 | 121 | 0.930 |
Why?
|
| Diet | 7 | 2020 | 418 | 0.910 |
Why?
|
| Humans | 93 | 2020 | 34475 | 0.830 |
Why?
|
| Prospective Studies | 25 | 2020 | 2461 | 0.750 |
Why?
|
| Accidental Falls | 4 | 2019 | 116 | 0.740 |
Why?
|
| Independent Living | 5 | 2020 | 95 | 0.720 |
Why?
|
| Eating | 3 | 2017 | 81 | 0.710 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2018 | 1523 | 0.700 |
Why?
|
| Muscle Strength | 7 | 2020 | 157 | 0.680 |
Why?
|
| Motor Activity | 6 | 2015 | 356 | 0.650 |
Why?
|
| Genome-Wide Association Study | 15 | 2018 | 555 | 0.640 |
Why?
|
| Longevity | 1 | 2020 | 24 | 0.640 |
Why?
|
| Parathyroid Hormone | 5 | 2012 | 47 | 0.620 |
Why?
|
| Dietary Supplements | 6 | 2018 | 197 | 0.590 |
Why?
|
| African Continental Ancestry Group | 10 | 2018 | 367 | 0.590 |
Why?
|
| Disabled Persons | 2 | 2012 | 101 | 0.570 |
Why?
|
| Pennsylvania | 8 | 2018 | 85 | 0.530 |
Why?
|
| Tennessee | 8 | 2018 | 107 | 0.530 |
Why?
|
| Amino Acids | 1 | 2017 | 54 | 0.500 |
Why?
|
| Body Weight | 7 | 2020 | 343 | 0.500 |
Why?
|
| Middle Aged | 31 | 2020 | 12703 | 0.500 |
Why?
|
| Follow-Up Studies | 14 | 2019 | 2366 | 0.490 |
Why?
|
| Vitamins | 3 | 2015 | 75 | 0.490 |
Why?
|
| Nutrition Policy | 3 | 2020 | 35 | 0.490 |
Why?
|
| Muscle, Skeletal | 7 | 2019 | 568 | 0.470 |
Why?
|
| Homebound Persons | 1 | 2015 | 9 | 0.460 |
Why?
|
| Cholecalciferol | 1 | 2015 | 25 | 0.460 |
Why?
|
| Food Services | 1 | 2015 | 21 | 0.460 |
Why?
|
| Cohort Studies | 19 | 2018 | 1910 | 0.440 |
Why?
|
| Behavior Therapy | 1 | 2014 | 107 | 0.410 |
Why?
|
| Health Status | 8 | 2018 | 411 | 0.400 |
Why?
|
| Blood Glucose | 7 | 2019 | 529 | 0.390 |
Why?
|
| Activities of Daily Living | 5 | 2014 | 267 | 0.390 |
Why?
|
| African Americans | 9 | 2018 | 1435 | 0.390 |
Why?
|
| Aged, 80 and over | 15 | 2020 | 4151 | 0.390 |
Why?
|
| Feeding Behavior | 4 | 2017 | 168 | 0.380 |
Why?
|
| Genetic Loci | 6 | 2018 | 146 | 0.370 |
Why?
|
| Dairy Products | 2 | 2017 | 13 | 0.360 |
Why?
|
| Proportional Hazards Models | 7 | 2014 | 803 | 0.360 |
Why?
|
| Cross-Sectional Studies | 12 | 2018 | 1607 | 0.360 |
Why?
|
| Risk Factors | 18 | 2019 | 4136 | 0.360 |
Why?
|
| Incidence | 11 | 2019 | 1289 | 0.350 |
Why?
|
| Geriatric Assessment | 9 | 2019 | 369 | 0.350 |
Why?
|
| Depression | 1 | 2014 | 458 | 0.340 |
Why?
|
| Nutritional Status | 4 | 2014 | 80 | 0.340 |
Why?
|
| Hand Strength | 4 | 2018 | 106 | 0.340 |
Why?
|
| Insulin | 4 | 2015 | 394 | 0.330 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2019 | 565 | 0.320 |
Why?
|
| Energy Intake | 7 | 2019 | 138 | 0.310 |
Why?
|
| Mortality | 4 | 2015 | 127 | 0.300 |
Why?
|
| Diet, Reducing | 4 | 2019 | 109 | 0.300 |
Why?
|
| Diet Surveys | 5 | 2019 | 56 | 0.300 |
Why?
|
| United States | 16 | 2019 | 4267 | 0.300 |
Why?
|
| Sarcopenia | 3 | 2019 | 67 | 0.290 |
Why?
|
| Retirement | 1 | 2008 | 13 | 0.290 |
Why?
|
| Linear Models | 7 | 2018 | 464 | 0.270 |
Why?
|
| Bone Density | 2 | 2019 | 208 | 0.270 |
Why?
|
| Cognition | 4 | 2016 | 576 | 0.270 |
Why?
|
| Muscular Atrophy | 1 | 2008 | 76 | 0.260 |
Why?
|
| Diabetes Mellitus | 2 | 2008 | 439 | 0.260 |
Why?
|
| Heart Diseases | 2 | 2018 | 124 | 0.260 |
Why?
|
| Longitudinal Studies | 7 | 2018 | 801 | 0.260 |
Why?
|
| Genotype | 8 | 2018 | 743 | 0.250 |
Why?
|
| Nutrition Assessment | 4 | 2011 | 55 | 0.250 |
Why?
|
| Gait | 3 | 2013 | 134 | 0.250 |
Why?
|
| Vegetables | 2 | 2010 | 41 | 0.240 |
Why?
|
| Fruit | 2 | 2010 | 57 | 0.240 |
Why?
|
| Adult | 16 | 2018 | 10015 | 0.230 |
Why?
|
| Ethnic Groups | 3 | 2017 | 483 | 0.230 |
Why?
|
| Pilot Projects | 2 | 2019 | 583 | 0.230 |
Why?
|
| Proteins | 3 | 2020 | 155 | 0.230 |
Why?
|
| Sex Factors | 7 | 2020 | 707 | 0.220 |
Why?
|
| Lung | 2 | 2018 | 279 | 0.210 |
Why?
|
| Thinness | 2 | 2015 | 34 | 0.200 |
Why?
|
| Confidence Intervals | 3 | 2009 | 155 | 0.200 |
Why?
|
| Diet, Mediterranean | 2 | 2014 | 32 | 0.200 |
Why?
|
| Alleles | 5 | 2014 | 257 | 0.190 |
Why?
|
| Cognition Disorders | 3 | 2014 | 390 | 0.190 |
Why?
|
| Meat | 2 | 2015 | 17 | 0.190 |
Why?
|
| Osteoporosis | 2 | 2019 | 74 | 0.180 |
Why?
|
| Adipose Tissue | 3 | 2011 | 365 | 0.180 |
Why?
|
| Frail Elderly | 2 | 2019 | 73 | 0.170 |
Why?
|
| Thigh | 2 | 2019 | 43 | 0.170 |
Why?
|
| Respiratory Function Tests | 2 | 2018 | 105 | 0.170 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2018 | 849 | 0.160 |
Why?
|
| Nutritional Sciences | 1 | 2020 | 9 | 0.160 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2020 | 19 | 0.160 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2019 | 10 | 0.160 |
Why?
|
| Soft Tissue Injuries | 1 | 2019 | 20 | 0.160 |
Why?
|
| Risk Assessment | 5 | 2018 | 1506 | 0.150 |
Why?
|
| Chi-Square Distribution | 4 | 2012 | 304 | 0.150 |
Why?
|
| Chronic Disease | 2 | 2012 | 438 | 0.150 |
Why?
|
| Dietary Fats | 3 | 2014 | 115 | 0.140 |
Why?
|
| Age Factors | 5 | 2018 | 1262 | 0.140 |
Why?
|
| Vitamin K | 1 | 2018 | 8 | 0.140 |
Why?
|
| Disability Evaluation | 3 | 2019 | 262 | 0.140 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 325 | 0.140 |
Why?
|
| Random Allocation | 1 | 2019 | 257 | 0.140 |
Why?
|
| Bone and Bones | 1 | 2019 | 99 | 0.140 |
Why?
|
| Lung Diseases | 1 | 2018 | 51 | 0.140 |
Why?
|
| Vesicular Transport Proteins | 1 | 2018 | 12 | 0.140 |
Why?
|
| Seafood | 1 | 2017 | 11 | 0.140 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2017 | 32 | 0.140 |
Why?
|
| Docosahexaenoic Acids | 1 | 2017 | 25 | 0.130 |
Why?
|
| Inflammation | 2 | 2012 | 557 | 0.130 |
Why?
|
| Appetite | 1 | 2017 | 24 | 0.130 |
Why?
|
| Osteoarthritis, Knee | 1 | 2018 | 96 | 0.130 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 183 | 0.130 |
Why?
|
| Genome, Human | 2 | 2018 | 136 | 0.130 |
Why?
|
| Absorptiometry, Photon | 4 | 2014 | 143 | 0.130 |
Why?
|
| Heart | 1 | 2018 | 191 | 0.130 |
Why?
|
| Lower Extremity | 1 | 2018 | 106 | 0.130 |
Why?
|
| Walking | 3 | 2013 | 217 | 0.130 |
Why?
|
| Genetics, Population | 1 | 2017 | 32 | 0.130 |
Why?
|
| Urinary Incontinence | 1 | 2017 | 68 | 0.130 |
Why?
|
| Dietary Carbohydrates | 2 | 2014 | 23 | 0.130 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2014 | 18 | 0.120 |
Why?
|
| Prevalence | 4 | 2018 | 1034 | 0.120 |
Why?
|
| Exercise Therapy | 2 | 2019 | 283 | 0.120 |
Why?
|
| Membrane Proteins | 2 | 2018 | 268 | 0.120 |
Why?
|
| Odds Ratio | 4 | 2017 | 480 | 0.120 |
Why?
|
| Health Behavior | 3 | 2014 | 246 | 0.120 |
Why?
|
| Meat Products | 1 | 2015 | 3 | 0.120 |
Why?
|
| Time Factors | 5 | 2015 | 2352 | 0.120 |
Why?
|
| Hyperinsulinism | 1 | 2015 | 14 | 0.120 |
Why?
|
| Hip Fractures | 2 | 2012 | 27 | 0.110 |
Why?
|
| Phenotype | 5 | 2015 | 656 | 0.110 |
Why?
|
| Insulin-Secreting Cells | 1 | 2015 | 56 | 0.110 |
Why?
|
| Epistasis, Genetic | 1 | 2015 | 44 | 0.110 |
Why?
|
| Hyperglycemia | 1 | 2015 | 88 | 0.110 |
Why?
|
| Single-Blind Method | 1 | 2015 | 214 | 0.110 |
Why?
|
| Coffea | 1 | 2014 | 1 | 0.110 |
Why?
|
| Stroke Volume | 1 | 2018 | 440 | 0.110 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2014 | 9 | 0.110 |
Why?
|
| Feasibility Studies | 1 | 2015 | 323 | 0.110 |
Why?
|
| Antidepressive Agents | 1 | 2014 | 78 | 0.110 |
Why?
|
| Hearing Loss | 1 | 2014 | 26 | 0.100 |
Why?
|
| Genetic Variation | 2 | 2012 | 254 | 0.100 |
Why?
|
| Apolipoprotein E4 | 1 | 2014 | 59 | 0.100 |
Why?
|
| Health Surveys | 2 | 2011 | 202 | 0.100 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2013 | 12 | 0.100 |
Why?
|
| Fasting | 2 | 2012 | 95 | 0.100 |
Why?
|
| Adiposity | 2 | 2012 | 204 | 0.100 |
Why?
|
| Muscle Weakness | 1 | 2014 | 37 | 0.100 |
Why?
|
| Health Education | 1 | 2014 | 170 | 0.100 |
Why?
|
| Nutrition Surveys | 5 | 2013 | 156 | 0.100 |
Why?
|
| Predictive Value of Tests | 3 | 2014 | 934 | 0.100 |
Why?
|
| Homozygote | 2 | 2010 | 59 | 0.100 |
Why?
|
| PPAR gamma | 2 | 2011 | 55 | 0.100 |
Why?
|
| Calcium, Dietary | 1 | 2013 | 21 | 0.100 |
Why?
|
| Trace Elements | 1 | 2013 | 7 | 0.100 |
Why?
|
| Carbohydrate Metabolism | 1 | 2012 | 21 | 0.100 |
Why?
|
| Lipoprotein Lipase | 1 | 2012 | 14 | 0.100 |
Why?
|
| Magnesium | 1 | 2013 | 30 | 0.100 |
Why?
|
| Receptors, Calcitriol | 1 | 2012 | 13 | 0.100 |
Why?
|
| Hyperparathyroidism | 1 | 2012 | 9 | 0.090 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2012 | 5 | 0.090 |
Why?
|
| Gene Frequency | 3 | 2018 | 222 | 0.090 |
Why?
|
| Seasons | 4 | 2015 | 94 | 0.090 |
Why?
|
| Insulin Resistance | 1 | 2015 | 488 | 0.090 |
Why?
|
| Homeostasis | 1 | 2012 | 137 | 0.090 |
Why?
|
| Linkage Disequilibrium | 4 | 2013 | 189 | 0.090 |
Why?
|
| Urban Population | 1 | 2012 | 97 | 0.090 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2012 | 54 | 0.090 |
Why?
|
| Knee | 1 | 2011 | 31 | 0.090 |
Why?
|
| Socioeconomic Factors | 2 | 2014 | 446 | 0.090 |
Why?
|
| Cation Transport Proteins | 1 | 2011 | 24 | 0.090 |
Why?
|
| Lipids | 1 | 2012 | 267 | 0.090 |
Why?
|
| Heart Failure | 1 | 2018 | 780 | 0.090 |
Why?
|
| Zinc | 1 | 2011 | 33 | 0.090 |
Why?
|
| Pain Measurement | 1 | 2012 | 385 | 0.090 |
Why?
|
| Calcium | 1 | 2013 | 343 | 0.080 |
Why?
|
| Reference Values | 1 | 2011 | 265 | 0.080 |
Why?
|
| Anthropometry | 2 | 2014 | 88 | 0.080 |
Why?
|
| Case-Control Studies | 3 | 2018 | 924 | 0.080 |
Why?
|
| Multicenter Studies as Topic | 1 | 2011 | 120 | 0.080 |
Why?
|
| Thiazolidinediones | 1 | 2011 | 51 | 0.080 |
Why?
|
| Quality of Life | 2 | 2019 | 1032 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2012 | 194 | 0.080 |
Why?
|
| Fractures, Bone | 1 | 2012 | 157 | 0.080 |
Why?
|
| Body Fat Distribution | 1 | 2010 | 34 | 0.080 |
Why?
|
| Resistance Training | 1 | 2011 | 84 | 0.080 |
Why?
|
| Europe | 3 | 2017 | 86 | 0.080 |
Why?
|
| Hypertension | 2 | 2014 | 1024 | 0.080 |
Why?
|
| Inflammation Mediators | 1 | 2010 | 107 | 0.080 |
Why?
|
| Hypoglycemic Agents | 1 | 2011 | 200 | 0.080 |
Why?
|
| Physical Endurance | 1 | 2008 | 42 | 0.070 |
Why?
|
| Energy Metabolism | 1 | 2010 | 169 | 0.070 |
Why?
|
| Age Distribution | 1 | 2009 | 211 | 0.070 |
Why?
|
| Health Status Disparities | 1 | 2009 | 138 | 0.070 |
Why?
|
| Oxygen Consumption | 2 | 2019 | 167 | 0.070 |
Why?
|
| Logistic Models | 2 | 2011 | 808 | 0.070 |
Why?
|
| Hospitalization | 1 | 2010 | 500 | 0.070 |
Why?
|
| Arteriosclerosis | 2 | 2005 | 150 | 0.070 |
Why?
|
| Patient Selection | 1 | 2008 | 291 | 0.060 |
Why?
|
| Exercise Test | 2 | 2019 | 247 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2007 | 194 | 0.060 |
Why?
|
| Atherosclerosis | 2 | 2013 | 837 | 0.060 |
Why?
|
| Forced Expiratory Volume | 2 | 2018 | 92 | 0.060 |
Why?
|
| Prognosis | 3 | 2018 | 1603 | 0.060 |
Why?
|
| Fibroblast Growth Factors | 2 | 2018 | 36 | 0.060 |
Why?
|
| Regression Analysis | 2 | 2018 | 310 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 1209 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 703 | 0.050 |
Why?
|
| Neuropsychological Tests | 2 | 2016 | 372 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2014 | 71 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2008 | 3812 | 0.050 |
Why?
|
| Quantitative Trait Loci | 2 | 2013 | 142 | 0.050 |
Why?
|
| Dietary Fiber | 1 | 2002 | 20 | 0.050 |
Why?
|
| Risk | 2 | 2014 | 325 | 0.050 |
Why?
|
| Cause of Death | 2 | 2012 | 245 | 0.040 |
Why?
|
| Biomass | 1 | 2020 | 4 | 0.040 |
Why?
|
| Abdominal Fat | 2 | 2011 | 52 | 0.040 |
Why?
|
| Cluster Analysis | 2 | 2011 | 128 | 0.040 |
Why?
|
| Smoking | 2 | 2018 | 544 | 0.040 |
Why?
|
| Muscle Development | 1 | 2020 | 52 | 0.040 |
Why?
|
| Subcutaneous Fat | 2 | 2011 | 52 | 0.040 |
Why?
|
| Muscles | 1 | 2020 | 67 | 0.040 |
Why?
|
| National Institute on Aging (U.S.) | 1 | 2019 | 8 | 0.040 |
Why?
|
| Maryland | 1 | 2019 | 28 | 0.040 |
Why?
|
| Residence Characteristics | 2 | 2012 | 188 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 755 | 0.040 |
Why?
|
| Tomography | 1 | 2019 | 6 | 0.040 |
Why?
|
| Hip | 1 | 2019 | 17 | 0.040 |
Why?
|
| Fatigue | 1 | 2019 | 90 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2011 | 509 | 0.040 |
Why?
|
| Young Adult | 2 | 2018 | 2825 | 0.040 |
Why?
|
| Weight Gain | 1 | 2019 | 117 | 0.040 |
Why?
|
| Molecular Epidemiology | 1 | 2018 | 21 | 0.040 |
Why?
|
| Geriatrics | 1 | 2019 | 88 | 0.040 |
Why?
|
| Vital Capacity | 1 | 2018 | 43 | 0.040 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2018 | 9 | 0.040 |
Why?
|
| Femur | 1 | 2019 | 82 | 0.040 |
Why?
|
| Hispanic Americans | 2 | 2018 | 948 | 0.040 |
Why?
|
| Lumbar Vertebrae | 1 | 2019 | 113 | 0.030 |
Why?
|
| Amidohydrolases | 1 | 2018 | 9 | 0.030 |
Why?
|
| Health Services for the Aged | 1 | 2018 | 27 | 0.030 |
Why?
|
| Myosin-Light-Chain Phosphatase | 1 | 2017 | 3 | 0.030 |
Why?
|
| Exercise Tolerance | 1 | 2019 | 140 | 0.030 |
Why?
|
| Actins | 1 | 2017 | 56 | 0.030 |
Why?
|
| Autoimmune Diseases | 1 | 2018 | 49 | 0.030 |
Why?
|
| Genomics | 1 | 2018 | 94 | 0.030 |
Why?
|
| Posture | 1 | 2017 | 60 | 0.030 |
Why?
|
| Postural Balance | 1 | 2017 | 152 | 0.030 |
Why?
|
| Publication Bias | 1 | 2015 | 8 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 149 | 0.030 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2015 | 9 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 922 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2014 | 3 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 2 | 0.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2014 | 40 | 0.030 |
Why?
|
| Asian Continental Ancestry Group | 1 | 2014 | 109 | 0.030 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2014 | 1 | 0.030 |
Why?
|
| Georgia | 1 | 2014 | 14 | 0.030 |
Why?
|
| Calcifediol | 1 | 2014 | 10 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 175 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2013 | 32 | 0.020 |
Why?
|
| Metagenomics | 1 | 2013 | 4 | 0.020 |
Why?
|
| North America | 1 | 2013 | 34 | 0.020 |
Why?
|
| TRPM Cation Channels | 1 | 2013 | 9 | 0.020 |
Why?
|
| Steroid Hydroxylases | 1 | 2012 | 2 | 0.020 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2012 | 5 | 0.020 |
Why?
|
| Medicare | 1 | 2014 | 217 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 612 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2013 | 148 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2012 | 48 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2012 | 131 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 83 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2013 | 193 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2012 | 194 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 113 | 0.020 |
Why?
|
| Triglycerides | 1 | 2012 | 249 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 230 | 0.020 |
Why?
|
| Distance Perception | 1 | 2011 | 3 | 0.020 |
Why?
|
| Child | 1 | 2018 | 2613 | 0.020 |
Why?
|
| Judgment | 1 | 2011 | 13 | 0.020 |
Why?
|
| Continental Population Groups | 1 | 2013 | 245 | 0.020 |
Why?
|
| Intention | 1 | 2011 | 31 | 0.020 |
Why?
|
| Arm | 1 | 2011 | 43 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 508 | 0.020 |
Why?
|
| Choristoma | 1 | 2011 | 17 | 0.020 |
Why?
|
| Organ Size | 1 | 2011 | 236 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2010 | 11 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2010 | 26 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2011 | 116 | 0.020 |
Why?
|
| Immunoassay | 1 | 2010 | 16 | 0.020 |
Why?
|
| International Cooperation | 1 | 2010 | 33 | 0.020 |
Why?
|
| Heterozygote | 1 | 2010 | 66 | 0.020 |
Why?
|
| Canada | 1 | 2010 | 69 | 0.020 |
Why?
|
| Adipokines | 1 | 2010 | 17 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 526 | 0.020 |
Why?
|
| Diet, Fat-Restricted | 1 | 2010 | 32 | 0.020 |
Why?
|
| Self Disclosure | 1 | 2010 | 23 | 0.020 |
Why?
|
| Adolescent | 1 | 2018 | 3799 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2010 | 66 | 0.020 |
Why?
|
| Water | 1 | 2010 | 70 | 0.020 |
Why?
|
| Baltimore | 1 | 2009 | 50 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2009 | 94 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2010 | 189 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2012 | 515 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 589 | 0.020 |
Why?
|
| Postmenopause | 1 | 2008 | 461 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 984 | 0.010 |
Why?
|
| Neoplasms | 1 | 2012 | 791 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2007 | 260 | 0.010 |
Why?
|
| North Carolina | 1 | 2002 | 1612 | 0.010 |
Why?
|